2023 PharmSci 360 Scientific Programming Committee
Otilia Koo, Ph.D., BMS (Chair)
Amit Desai, Ph.D., Astellas Pharma (Vice-Chair)
Kevin Litwilier, Ph.D., OnKure Therapeutics (Past Chair)
Discovery and Basic Research Track
Patrick Ronaldson, Ph.D., University of Arizona College of Medicine (Track Chair)
Carsten Ehrhardt, Ph.D., Trinity College Dublin (Sub-Track Leader)
Sudip Das, MPharm, Ph.D., Butler University (Sub-Track Leader)
Preclinical and Translational Sciences Track
Yurong Lai, Ph.D., Gilead Sciences Inc. (Track Chair)
Jaya Vaidyanathan, Ph.D., US FDA (Sub-Track Leader)
Fei Hua, Ph.D., Applied BioMath (Sub-Track Leader)
Bioanalytics Track
Catherine Vrentas, Ph.D., MBA, PPD (Track Chair)
Catherine Brockus, Ph.D., Eli Lilly and Company (Sub-Track Leader)
Long Yuan, Ph.D., Biogen (Sub-Track Leader)
Manufacturing and Analytical Characterization Track
Sayantan Chattoraj, Ph.D., GlaxoSmithKline (Track Chair)
Thilak Mudalige, Ph.D., US FDA (Sub-Track Leader)
Fengqiang Wang, Ph.D., Merck (Sub-Track Leader)
Formulation and Delivery Track
Xiuling Lu, Ph.D., University of Connecticut (Track Chair)
Mary Krause, Ph.D., Bristol Myers Squibb (Sub-Track Leader)
Heidi Mansour, Ph.D., R.Ph., Florida International University (Sub-Track Leader)